Non-small cell lung cancer

You have access
Serum CEA and CYFRA Levels in ALK-rearranged NSCLC Patients: Correlation With Distant Metastasis
TAKESHI NUMATA, TAKEO ENDO, HIDETOSHI YANAI, KYOKO OTA, YUSUKE YAMAMOTO, KEI SHIMIZU, HIDEYASU YAMADA, KENJI HAYASHIHARA, SHINICHIRO OKAUCHI, HIROAKI SATOH, YUTAKA YAMADA, TOMOHIRO TAMURA, KAZUTO SAITO, NORIHIRO KIKUCHI, KOICHI KURISHIMA, HIROICHI ISHIKAWA, HIROKO WATANABE, TOSHIHIRO SHIOZAWA, NOBUYUKI HIZAWA, YASUNORI FUNAYAMA, SHIGEN HAYASHI, HIROYUKI NAKAMURA and TAKAAKI YAMASHITA

In Vivo July 2020, 34 (4) 2095-2100; DOI: https://doi.org/10.21873/invivo.12013
You have access
Pleural Neutrophil-to-Lymphocyte Ratio May Be Associated With Early Disease Progression in Stage IV Non-small Cell Lung Cancer
JEONG UK LIM, CHANG DONG YEO, HYUNG WOO KIM, HYE SEON KANG, CHAN KWON PARK, JU SANG KIM, JIN WOO KIM, SEUNG JOON KIM and SANG HAAK LEE

In Vivo July 2020, 34 (4) 2179-2185; DOI: https://doi.org/10.21873/invivo.12027
You have access
Comparison of the Efficacy of EGFR Tyrosine Kinase Inhibitors Erlotinib and Low-dose Osimertinib on a PC-9-GFP EGFR Mutant Non-small-cell Lung Cancer Growing in the Brain of Nude Mice
YUKI KATSUYA, KENTARO MIYAKE, TAKASHI HIGUCHI, HIROMICHI OSHIRO, NORIHIKO SUGISAWA, SHREE RAM SINGH, YASUSHI GOTO, MING ZHAO and ROBERT M. HOFFMAN

In Vivo May 2020, 34 (3) 1027-1030; DOI: https://doi.org/10.21873/invivo.11871
You have access
Non-small Cell Lung Cancer as a Chronic Disease – A Prospective Study from the Czech TULUNG Registry
MONIKA BRATOVA, BARA KARLINOVA, JANA SKRICKOVA, MILOS PESEK, VITEZSLAV KOLEK, LEONA KOUBKOVA, MICHAL HRNCIARIK, JANA KREJCI, MAGDA BARINOVA, LIBOR HAVEL, IVONA GRYGARKOVA and KRISTIAN BRAT

In Vivo January 2020, 34 (1) 369-379; DOI: https://doi.org/10.21873/invivo.11783
You have access
Factors Associated With Distant Metastasis in EGFR-mutated Non-small Cell Lung Cancer Patients: Logistic Analysis
HIROKO WATANABE, SHINICHIRO OKAUCHI, KUNIHIKO MIYAZAKI, HIROAKI SATOH and NOBUYUKI HIZAWA

In Vivo July 2019, 33 (4) 1369-1372; DOI: https://doi.org/10.21873/invivo.11613
You have access
Prognostic Value of Serum Tumor Markers in Patients With Stage III NSCLC Treated With Chemoradiotherapy
TAKAAKI TOKITO, KOICHI AZUMA, KAZUHIKO YAMADA, YOSHIKO NAITO, NORIKAZU MATSUO, HIDENOBU ISHII, HIROKI NATORI, TAKASHI KINOSHITA and TOMOAKI HOSHINO

In Vivo May 2019, 33 (3) 889-895; DOI: https://doi.org/10.21873/invivo.11555
You have access
Combined Chemoradiotherapy-induced Weight Loss Decreases Survival in Locally Advanced Non-small Cell Lung Cancer Patients
YI-JUN KIM, CHANGHOON SONG, KEUN-YONG EOM, IN AH KIM and JAE-SUNG KIM

In Vivo May 2019, 33 (3) 955-961; DOI: https://doi.org/10.21873/invivo.11564
You have access
Analysis of Pleiotropic Effects of Nivolumab in Pretreated Advanced or Recurrent Non-small Cell Lung Cancer Cases
YUMIKO AKANO, KOZO KURIBAYASHI, NORIHIKO FUNAGUCHI, YUICHI KODA, ERIKO FUJIMOTO, KOJI MIKAMI, TOSHIYUKI MINAMI, RYO TAKAHASHI, TAKASHI YOKOI and TAKASHI KIJIMA

In Vivo March 2019, 33 (2) 507-514; DOI: https://doi.org/10.21873/invivo.11503
You have access
Phase II Study of Weekly Amrubicin for Refractory or Relapsed Non-small Cell Lung Cancer
CHIYOE KITAGAWA, MASAHIRO IWASAKU, YOSHIHITO KOGURE, MASAHIKO ANDO, HIROSHIGE YOSHIOKA, AKIHIRO NISHIYAMA, NAOKI WATANABE, KEI KUNIMASA, KAZUYA TSUBOUCHI, SAORI OKA and HIDEO SAKA

In Vivo January 2019, 33 (1) 163-166; DOI: https://doi.org/10.21873/invivo.11453
You have access
Prognostic Value of Red Blood Cell Distribution Width in Non-small Cell Lung Cancer Treated With Anti-programmed Cell Death-1 Antibody
TATSUNORI KIRIU, MASATSUGU YAMAMOTO, TATSUYA NAGANO, KIYOKO KOYAMA, MASAHIRO KATSURADA, DAISUKE TAMURA, KYOSUKE NAKATA, MOTOKO TACHIHARA, KAZUYUKI KOBAYASHI and YOSHIHIRO NISHIMURA

In Vivo January 2019, 33 (1) 213-220; DOI: https://doi.org/10.21873/invivo.11462

Main menu

User menu

Search

Non-small cell lung cancer

Pages